Catalyst OrthoScience receives FDA clearance for novel shoulder fracture system
Catalyst OrthoScience, a medical technology company specialising in shoulder arthroplasty, has announced FDA 510(k) clearance for its Catalyst Fracture Shoulder System. The system, designed for reverse shoulder arthroplasty in cases of proximal humeral fractures (PHFs), aims to tackle the complexities associated with tuberosity fixation and healing.